Elan ELN, which has a 25% ownership stake in Pfizer (PFE) and Johnson & Johnson's failed...

|About: Elan Corporation, plc (ELN)|By:, SA News Editor

Elan ELN, which has a 25% ownership stake in Pfizer (PFE) and Johnson & Johnson's failed bapineuzumab project, is also trading down after hours, along with Eli Lilly (LLY), who has a similar Alzheimer's candidate, solanezumab, for which clinical results are expected in coming weeks. ELN -8.7%, LLY -2.1%.